Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Hosker

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Postgraduate Medical Journal|August 1, 1983
Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BPJ P Hosker, D P Jewell
Lancet (London, England)|September 18, 1982
Insulin treatment of newly-presenting ketotic diabetic patients into the honeymoon periodJ P Hosker, R C Turner
Diabetes Care|February 1, 1989
Unbiased and flexible iterative computer program to achieve glucose clampingD R Matthews, J P Hosker
Diabetes Research and Clinical Practice|January 1, 1991
The physiological action of gliclazide: beta-cell function and insulin resistanceD R Matthews, J P Hosker, I Stratton
Journal of the Royal Society of Medicine|July 1, 1983
Communicating hydrocephalus in the intellectual deterioration of diabetes mellitusD B Jones, J P Hosker, C M Asplin
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1988
Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetesJ P Hosker, M A Burnett, D R Matthews, et al.
Metabolism: Clinical and Experimental|September 1, 1993
Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetesJ P Hosker, M A Burnett, D R Matthews, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1993
Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivityJ P Hosker, S Kumar, C Gordon, et al.
Metabolism: Clinical and Experimental|August 1, 1989
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapyJ P Hosker, A S Rudenski, M A Burnett, et al.
Metabolism: Clinical and Experimental|June 1, 1988
The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion ratesA S Rudenski, J P Hosker, M A Burnett, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Postgraduate Medical Journal|August 1, 1983
Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BPJ P Hosker, D P Jewell
Lancet (London, England)|September 18, 1982
Insulin treatment of newly-presenting ketotic diabetic patients into the honeymoon periodJ P Hosker, R C Turner
Diabetes Care|February 1, 1989
Unbiased and flexible iterative computer program to achieve glucose clampingD R Matthews, J P Hosker
Diabetes Research and Clinical Practice|January 1, 1991
The physiological action of gliclazide: beta-cell function and insulin resistanceD R Matthews, J P Hosker, I Stratton
Journal of the Royal Society of Medicine|July 1, 1983
Communicating hydrocephalus in the intellectual deterioration of diabetes mellitusD B Jones, J P Hosker, C M Asplin
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1988
Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetesJ P Hosker, M A Burnett, D R Matthews, et al.
Metabolism: Clinical and Experimental|September 1, 1993
Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetesJ P Hosker, M A Burnett, D R Matthews, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1993
Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivityJ P Hosker, S Kumar, C Gordon, et al.
Metabolism: Clinical and Experimental|August 1, 1989
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapyJ P Hosker, A S Rudenski, M A Burnett, et al.
Metabolism: Clinical and Experimental|June 1, 1988
The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion ratesA S Rudenski, J P Hosker, M A Burnett, et al.
Pageof 2